[1]郑鑫辉,崔慧丽,杨铁毅,等.粪乳铁蛋白、维生素D水平与克罗恩病患者骨质疏松的相关性[J].医学信息,2021,34(05):114-116,123.[doi:10.3969/j.issn.1006-1959.2021.05.032]
　ZHENG Xin-hui,CUI Hui-li,YANG Tie-yi,et al.Correlation Between Fecal Lactoferrin,Vitamin D Levels and Osteoporosis in Crohn’s Disease[J].Medical Information,2021,34(05):114-116,123.[doi:10.3969/j.issn.1006-1959.2021.05.032]
点击复制

粪乳铁蛋白、维生素D水平与克罗恩病患者骨质疏松的相关性()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年05期
页码:
114-116,123
栏目:
临床研究
出版日期:
2021-03-01

文章信息/Info

Title:
Correlation Between Fecal Lactoferrin,Vitamin D Levels and Osteoporosis in Crohn’s Disease
文章编号:
1006-1959（2021）05-0114-04
作者:
郑鑫辉; 崔慧丽; 杨铁毅; 等
（1.宁夏医科大学研究生院，宁夏 银川 750004； 2.郑州大学第一附属医院神经内科，河南 郑州 450000； 3.上海市浦东新区公利医院骨科，上海 200135）
Author(s):
ZHENG Xin-hui; CUI Hui-li; YANG Tie-yi; et al.
(1.Graduate School,Ningxia Medical University,Yinchuan 750004,Ningxia,China; 2.Department of Neurdogy,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,Henan,China; 3.Department of Orthopedics,Gongli Hospital,Pudong New Area,Shanghai
关键词:
克罗恩病; 粪乳铁蛋白; 骨密度; 维生素D
Keywords:
Crohn ’s Disease; Fecal lactoferrin; Bone mineral density; Vitamin D
分类号:
R574
DOI:
10.3969/j.issn.1006-1959.2021.05.032
文献标志码:
A
摘要:
目的 评估肠道炎症的严重程度与克罗恩病（CD）患者骨密度（BMD）之间的关系以及维生素D对克罗恩病患者骨密度的影响。方法 选取2020年1月~10月在我院就诊的46例克罗恩病患者作为病例组，另外选取同期20例健康体检者作为健康对照组，利用经典CDAI评分标准评估克罗恩病患者的病情严重程度，Lunar Prodigy双能X射线骨密度仪及酶联免疫法评估并比较两组的骨密度、粪乳铁蛋白及维生素D水平，分析克罗恩病患者粪乳铁蛋白水平与CDAI指数，骨密度与粪乳铁蛋白、维生素D水平的相关性。结果 病例组乳铁蛋白水平高于健康对照组，差异有统计学意义（P＜0.05）；病例组骨密度、维生素D水平低于健康对照组，差异有统计学意义（P＜0.05）；克罗恩病患者骨密度与粪乳铁蛋白、维生素D水平无相关性。结论 粪乳铁蛋白含量可以作为反映肠道炎症严重程度，克罗恩病患者易出现骨密度下降，其机制可能与维生素D吸收不良有关。
Abstract:
Objective To evaluate the relationship between the severity of intestinal inflammation and the patient’s bone density (BMD) and the effect of vitamin D on the bone density of patients with Crohn’s disease (CD).Methods A total of 46 patients with Crohn’s disease who were treated in our hospital from January to October 2020 were selected as the case group, and 20 healthy subjects were selected as the healthy control group during the same period.The classic CDAI scoring standard was used to assess the severity of Crohn’s disease. The Lunar Prodigy dual-energy X-ray bone densitometer and enzyme-linked immunoassay were used to assess and compare the bone density, fecal lactoferrin and vitamin D levels of the two groups.Analyze the correlation between fecal lactoferrin level and CDAI index, bone density and fecal lactoferrin and vitamin D levels in patients with Crohn’s disease.Results The lactoferrin level in the case group was higher than that in the healthy control group,the difference was statistically significant (P＜0.05);The bone density and vitamin D levels of the case group were lower than those of the healthy control group,the difference was statistically significant (P＜0.05);Tthere was no correlation between bone density and the level of fecal lactoferrin and vitamin D.Conclusion The content of fecal lactoferrin can be used as a reflection of the severity of intestinal inflammation. Patients with Crohn’s disease are prone to decrease in bone density, and the mechanism may be related to malabsorption of vitamin D.

参考文献/References:

[1]Schüle S,Rossel JB,Frey D,et al.Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study[J].Medicine,2017,96(22):e6788. [2]Ewid M,Al Mutiri N,Al Omar K,et al.Updated bone mineral density status in Saudi patients with inflammatory bowel disease[J].World Journal of Gastroenterology,2020,26(35):5343-5353. [3]Rubio MG,Amo-Mensah K,Gray JM,et al.Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease[J].World Journal of Gastrointestinal Pathophysiology,2019,10(5):54-63. [4]Kraemer A,Bulgakova T,Schukina O,et al.Automated Fecal Biomarker Profiling- a Convenient Procedure to Support Diagnosis for Patients with Inflammatory Bowel Diseases[J].Clinical Laboratory,2020,66(7). [5]Locantore P,Del Gatto V,Gelli S,et al.The Interplay between Immune System and Microbiota in Osteoporosis[J].Mediators of Inflammation,2020(2020):3686749. [6]Mena Bares LM,Benítez Cantero JM,Iglesias Flores E,et al.Bile acid malabsorption in patients with chronic diarrhea and Crohn’s disease[J].Revista Espanola De Enfermedades Digestivas:Organo Oficial De La Sociedad Espanola de Patologia Digestiva,2019,111(1):40-45. [7]Rivera ED,Coffey JC,Walsh D,et al.The Mesentery,Systemic Inflammation,and Crohn’s Disease[J].Inflammatory Bowel Diseases,2019,25(2):226-234. [8]Hanafy AS,Monir MH,Abdel Malak H,et al.A Simple Noninvasive Score Predicts Disease Activity and Deep Remission in Ulcerative Colitis[J].Inflammatory Intestinal Diseases,2018,3(1):16-24. [9]Klimczak K,Lykowska-Szuber L,Eder P,et al.The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn’s disease activity[J].European Journal of Internal Medicine,2015,26(8):623-627. [10]Karnsund S,Lo B,Bendtsen F,et al.Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease[J].World Journal of Gastroenterology,2020,26(35):5362-5374. [11]Nishida A,Inoue R,Inatomi O,et al.Gut microbiota in the pathogenesis of inflammatory bowel disease[J].Clinical Journal of Gastroenterology,2018,11(1):1-10. [12]Sgambato D,Gimigliano F,Musis C de,et al.Bone alterations in inflammatory bowel diseases[J].World Journal of Clinical Cases,2019,7(15):1908-1925. [13]Kotze LM d S,Costa CT,Cavassani MF,et al.Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease[J].Revista da Associacao Medica Brasileira(1992),2017,63(1):13-17. [14]Cantorna MT,Rogers CJ,Arora J.Aligning the Paradoxical Role of Vitamin D in Gastrointestinal Immunity[J].Trends in Endocrinology and Metabolism,2019,30(7):459-466. [15]Nygaard L,Skallerup A,Olesen SS,et al.Osteoporosis in patients with intestinal insufficiency and intestinal failure:Prevalence and clinical risk factors[J].Clinical Nutrition,2018,37(5):1654-1660.

相似文献/References:

[1]曾 翔,文 星,常一航,等.营养风险筛查和BMI在克罗恩病患者营养评估中的应用[J].医学信息,2019,32(08):133.[doi:10.3969/j.issn.1006-1959.2019.08.039]
　ZENG Xiang,WEN Xing,CHANG Yi-hang,et al.Application of Nutritional Risk Screening and BMI in Nutritional Assessment of Patients with Crohn's Disease[J].Medical Information,2019,32(05):133.[doi:10.3969/j.issn.1006-1959.2019.08.039]
[2]王莹洁,戴迟兵.益生菌在炎症性肠病中的应用研究[J].医学信息,2020,33(22):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
　WANG Ying-jie,DAI Chi-bing.Study on the Application of Probiotics in Inflammatory Bowel Disease[J].Medical Information,2020,33(05):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
[3]郑鑫辉,崔慧丽,邵 进,等.克罗恩病患者骨质疏松症的影响因素分析[J].医学信息,2021,34(08):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
　ZHENG Xin-hui,CUI Hui-li,SHAO Jin,et al.Analysis of Influencing Factors of Osteoporosis in Patients with Crohn’s Disease[J].Medical Information,2021,34(05):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
[4]马靖琳,王 婷,肖红斌,等.基于公共数据库分析FOXM1在软组织肉瘤中的表达及临床预后意义[J].医学信息,2024,37(01):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]
　MA Jing-lin,WANG Ting,XIAO Hong-bin,et al.Expression and Prognostic Significance of FOXM1 Gene in Soft Tissue Sarcomas Based on the Public Database[J].Medical Information,2024,37(05):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]
[5]黄晓东,黄 衔,梁靖华,等.基于m6A相关长链非编码RNA鉴定克罗恩病的潜在诊断生物标志物[J].医学信息,2024,37(01):10.[doi:10.3969/j.issn.1006-1959.2024.01.002]
　HUANG Xiao-dong,HUANG Xian,LIANG Jing-hua,et al.Identification of Potential Diagnostic Biomarkers for Crohn’s Disease Based on m6A-related Long Non-coding RNAs[J].Medical Information,2024,37(05):10.[doi:10.3969/j.issn.1006-1959.2024.01.002]

更新日期/Last Update: 1900-01-01